Bendamustine

Bendamustine is an antineoplastic (anti-cancer) drug belonging to the class of alkylating agents, used to treat certain types of blood and lymphatic system cancers. The primary indications include chronic lymphocytic leukemia (CLL), certain forms of non-Hodgkin lymphoma (NHL), and multiple myeloma. Bendamustine works by damaging the DNA of cancer cells, preventing their replication and causing cell death. The drug is administered intravenously via slow infusion in a hospital setting under the supervision of an oncologist. It is often combined with other chemotherapy agents to improve treatment effectiveness. Possible side effects include bone marrow suppression, increased risk of infections, nausea, fatigue, and others. Before use, patients should consult their physician and undergo necessary examinations to assess overall health and rule out contraindications.

Wikipedia page List of medicines with this active substance